Validation of folate in a convenient yeast assay suited for identification of inhibitors of Alzheimer's amyloid-β aggregation

Journal of Alzheimer's Disease

Volumn 15, Issue 3, 2008, Pages 391-396

  Macreadie, Ian ^a   Lotfi Miri, Mehrnoush ^a   Mohotti, Sameera ^a,b   Shapira, Deborah ^a   Bennett, Louise ^a   Varghese, Joseph ^a  

^a CSIRO   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Aggregation; Alzheimer's disease chemo preventatives; Amyloid ; Flow cytometry; Folate; High throughput screening; Oligomerization; Saccharomyces cerevisiae; Yeast assays

Indexed keywords

AMYLOID BETA PROTEIN; FOLIC ACID; FOLINIC ACID; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; FLUORESCENCE; FOLIC ACID DEFICIENCY; NONHUMAN; OLIGOMERIZATION; PLASMID; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; SACCHAROMYCES CEREVISIAE; YEAST;

EID: 57349160497     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-15305     Document Type: Article

References (30)

1. M.C. Anguera, J.R. Suh, H. Ghandour, I.M. Nasrallah, J. Selhub and P.J. Stover, Methenyltetrahydrofolate synthetase regulates folate turnover and accumulation, J Biol Chem 278 (2003), 29856-29862.
2. S.N. Bagriantsev, V.V. Kushnirov and S.W. Liebman, Analysis of amyloid aggregates using agarose gel electrophoresis, Methods Enzymol 412 (2006), 33-48.
3. A.M. Bayly, J.M. Berglez, O. Patel, L.A. Castelli, E.G. Hankins, P. Coloe, C. Hopkins Sibley and I.G. Macreadie, Folic acid utilisation related to sulfa drug resistance in Saccharomyces cerevisiae, FEMS Microbiol Lett 204 (2001), 387-390.
4. P. Bharadwaj, L. Waddington, J. Varghese and I.G. Macreadie, A new method to measure cellular toxicity of non-fibrillar and fibrillar Alzheimer's Aβ using yeast, J Alzheimers Dis 13 (2008) 147-150.
5. J. Caine, S. Sankovich, H. Antony, L. Waddington, P. Macreadie, J. Varghese and I. Macreadie, Alzheimer's Aβ fused to green fluorescent protein induces growth stress and a heat shock response, FEMS Yeast Res 7 (2007), 1230-1236.
6. A. Chan and T.B. Shea, Folate deprivation increases presenilin expression, γ-secretase activity, and Aβ levels in murine brain: potentiation by ApoE deficiency and alleviation by dietary S-adenosyl methionine, J Neurochem 102 (2007), 753-760.
7. R. Clarke, A.D. Smith, K.A. Jobst, H. Refsum, L. Sutton and P.M. Ueland, Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease, Arch Neurol 55 (1998), 1449-1455.
8. A. Coppola, A. D'Angelo, I. Fermo, G. Mazzola, M.N.D.D. Minno, A. Cajani, A. Sala, Angelo; G. Folco, E. Tremoli and G.D. Minno, Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate, Br J Haematol 131 (2005), 100-108.
9. P.J. Crouch, S.M. Harding, A.R. White, J. Camakaris, A.I. Bush and C.L. Masters. Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease, Int J Biochem Cell Biol 40 (2008), 181-198.
10. M. Fenech, C. Aitken and J. Rinaldi, Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults, Carcinogenesis 19 (1998) 1163-1171.
11. M. Fenech, Nutrition and genome health, Forum Nutr 60 (2007), 49-65.
12. R.D. Gietz and R.A. Woods, Yeast transformation by the LiAc/SS Carrier DNA/PEG method, Methods Mol Biol 313 (2006), 107-120.
13. T.E. Golde, Disease modifying therapy for AD?, J Neurochem 99 (2006), 689-707.
14. M. Hashimoto, E. Rockenstein, L. Crews and E. Masliah, Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases, Neuromolecular Med 4 (2003), 21-36.
15. A.V. Hoffbrand and D.G. Weir, The history of folic acid, Br J Haematol 113 (2001), 579-589.
16. W. Kim, Y. Kim, J. Min, D.J. Kim, Y.T. Chang and M.H. Hecht, A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide, ACS Chem Biol 1 (2006), 461-469.
17. J-M. Kim, R. Stewart, S-W. Kim, S-J Yang, H-Y. Shin, I-S Shin and J-S Yoon, Changes in folate, vitamin B12, and homocysteine associated with incident dementia, J Neurol Neurosurg Psychiatry (2008), in press.
18. I.I. Kruman, T.S. Kumaravel, A. Lohani, W.A. Pedersen, R.G. Cutler, Y. Kruman, J. Haughey, J. Lee, M. Evans and M.P. Mattson, Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease, J Neurosci 22 (2002), 1752-1762.
19. J.A. Luchsinger and R. Mayeux, Dietary factors and Alzheimer's disease, Lancet Neurol 3 (2004), 579-587.
20. O. Mayer Jr, J. Simon, H. Rosolova, M. Hromadka, I. Subrt and I. Vobrubova, The effects of folate supplementation on some coagulation parameters and oxidative status surrogates, Eur J Clin Pharmacol 58 (2002), 1-5.
21. A.M. Minino, M.P. Heron, S.L. Murphy and K.D. Kochanek, Deaths: final data for 2004, Natl Vital Stat Rep 55 (2007), 1-119.
22. E. Nakano, J.A. Higgins and H.J. Powers, Folate protects against oxidative modifications of human LDL, Br J Nutr 86 (2001), 637-639.
23. K.J. Pak, S.L. Chan and M.P. Mattson, Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid β-peptide, Neuromolecular Med 3 (2003), 119-128.
24. B.M. Rezk, G.R.M.M. Haenen, W.J.F van der Vijgh and A. Bast, Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity. Identification of the antioxidant pharmacophore, FEBS Lett 555 (2003), 601-605.
25. J.M. Serot, D. Christmann, T. Dubost, M.C. Bene and G.C. Faure, CSF-folate levels are decreased in late-onset AD patients, J Neural Transm 108 (2001), 93-99.
26. Y.M. Smulders and C.D. Stehouwer, Folate metabolism and cardiovascular disease, Semin Vasc Med 5 (2005), 87-97.
27. D.A. Snowdon, C.L. Tully, C.D. Smith, K.P. Riley and W.R. Markesbery, Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study, Am J Clin Nutr 71 (2000), 993-998.
28. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan and D.J. Selkoe, Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416 (2002), 535-539.
29. C. Wurth, N.K. Guimard and M.H. Hecht, Mutations that reduce aggregation of the Alzheimer's Aβ42 peptide: an unbiased search for the sequence determinants of Aβ amyloidogenesis, J Mol Biol 319 (2002), 1279-1290.
30. R. Yaari and J. Corey-Bloom, Alzheimer's disease, Semin Neurol 27 (2007), 32-41.